Acasti Pharma Inc (ACST)
2.73
+0.02
(+0.92%)
USD |
NASDAQ |
May 21, 16:00
2.65
-0.08
(-2.93%)
After-Hours: 20:00
Acasti Pharma Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2022 | 0.778M |
| September 30, 2022 | 0.859M |
| June 30, 2022 | 0.964M |
| March 31, 2022 | |
| December 31, 2021 | 0.238M |
| September 30, 2021 | 0.813M |
| June 30, 2021 | 0.448M |
| March 31, 2021 | |
| December 31, 2020 | 0.619M |
| September 30, 2020 | 0.625M |
| June 30, 2020 | 0.495M |
| March 31, 2020 | |
| December 31, 2019 | 1.191M |
| September 30, 2019 | 0.9609M |
| June 30, 2019 | 1.406M |
| March 31, 2019 | |
| December 31, 2018 | 1.382M |
| September 30, 2018 | 0.9071M |
| June 30, 2018 | 0.4699M |
| March 31, 2018 | |
| December 31, 2017 | 0.3006M |
| September 30, 2017 | 0.1959M |
| June 30, 2017 | 0.0846M |
| November 30, 2016 | 0.1096M |
| August 31, 2016 | 0.0464M |
| Date | Value |
|---|---|
| May 31, 2016 | 0.1074M |
| February 29, 2016 | |
| November 30, 2015 | 0.1346M |
| August 31, 2015 | 0.1472M |
| May 31, 2015 | 0.2192M |
| February 28, 2015 | 0.2001M |
| November 30, 2014 | 0.2647M |
| August 31, 2014 | 0.5889M |
| May 31, 2014 | 0.6579M |
| February 28, 2014 | 0.3551M |
| November 30, 2013 | 0.4451M |
| August 31, 2013 | 0.3028M |
| May 31, 2013 | 0.5855M |
| February 28, 2013 | 0.1714M |
| November 30, 2012 | 1.129M |
| August 31, 2012 | 0.7061M |
| May 31, 2012 | 0.5879M |
| February 29, 2012 | 0.0055M |
| November 30, 2011 | 0.4823M |
| August 31, 2011 | 0.4973M |
| May 31, 2011 | 0.1685M |
| February 28, 2011 | 0.0541M |
| November 30, 2010 | |
| August 31, 2010 | |
| May 31, 2010 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.238M
Minimum
Dec 2021
1.406M
Maximum
Jun 2019
0.7831M
Average
0.7955M
Median
Accounts Receivable (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 24.09M |
| Edesa Biotech Inc | 1.112M |
| Lexaria Bioscience Corp | -- |
| Xenon Pharmaceuticals Inc | 0.833M |
| ESSA Pharma Inc | 0.2152M |